The Rising Global Burden of IBD and the Need for Better Diagnostics
The global In-vitro Inflammatory Bowel Disease (IBD) Diagnostics Market is poised for substantial growth over the next decade, projected to expand from US$ 1.6 Bn in 2023 to over US$ 2.9 Bn by 2034, at a steady CAGR of 5.6% during the forecast period 2024–2034. This growth is primarily driven by rising global incidence of Crohn’s disease and ulcerative colitis, improved diagnostic...
0 Comments 0 Shares 10 Views 0 Reviews